About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, October 17th, 2014

The QualityStocks
Daily Stock List

graphic
graphic

FluoroPharma Medical, Inc. (FPMI)

TaglichBrothers reported earlier on FluoroPharma Medical, Inc. (FPMI), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Based in Montclair, New Jersey, FluoroPharma Medical, Inc. specializes in the development of novel diagnostic imaging products that use Positron Emission Tomography (PET) technology for the detection and assessment of disease before clinical manifestation. The Company is a biopharmaceutical entity engaged in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. FluoroPharma Medical has licensed technology from the Massachusetts General Hospital in Boston, Massachusetts.

The Company’s initial focus is the development of innovative PET imaging agents. It is advancing two products in clinical trials for assessment of acute and chronic forms of coronary artery disease. The design of these first in class agents is to target, quickly, myocardial cells.

Other products in development include agents for detection of inflamed atherosclerotic plaque in peripheral arteries, agents with the potential to image Alzheimer's disease, and agents that could potentially be used for imaging specific cancers. Patents related to FluoroPharma Medical’s portfolio of imaging compounds have been issued in the U.S., Europe, China, Japan, Canada, Australia, and Mexico.   

CardioPET™ is one of FluoroPharma's first in class PET imaging products. CardioPET™ is a perfusion and fatty acid uptake indicator, designed for use as a cardiac imaging agent. It may be a more specific alternative to presently available diagnostic tests. FluoroPharma Management believes its pharmacokinetic characteristics could be especially valuable in patients who are unable to exercise.

The Company also has its BFPET PET Scan Imaging Agent. BFPET is a Flourine-18 labeled tracer, designed to enter the myocardial cells in direct proportion to blood flow and cell membrane potential. FluoroPharma also has its VasoPET. Through targeting the active adenosine phosphate molecule receptors associated with inflammatory conditions, the VasoPET imaging agent allows FluoroPharma to visualize potential areas that may cause embolisms and thrombosis.

In addition, the Company has its AZPET PET Scan Imaging Agent. AZPET attaches to the amyloid deposits (plaque) in the brain and makes them visible on a PET Scan. Consequently, this allows for the early detection of Alzheimer's disease.

This month, FluoroPharma Medical announced that its abstract has been accepted for oral presentation at the Annual Congress of the European Association of Nuclear Medicine (EANM), October 18 - 22, 2014, in Gothenburg, Sweden. Data from the Company’s continuing Phase II clinical trial for CardioPET (18F FCPHA) to assess myocardial perfusion and fatty acid uptake in coronary artery disease (CAD) patients, will be presented at the session: Cardiovascular System: Cardiac PET Imaging, on Sunday, October 19, 2014, by Dr. Fabian Demeure, a Cardiologist at Cliniques Universitaires Saint Luc, Bruxelles.

FluoroPharma Medical, Inc. (FPMI), closed Friday's trading session at $0.53, even for the day. The average volume for the last 60 days is 26,820 and the stock's 52-week low/high is $0.46/$0.92.

Premier Biomedical, Inc. (BIEI)

PennyStocks24, Information Solutions Group, and FeedBlitz reported earlier on Premier Biomedical, Inc. (BIEI), and we choose to report on the Company as well, here at the QualityStocks Daily Newsletter.

Founded in 2010, Premier Biomedical, Inc. is a research-based medical development company. Its intention is to discover and develop medical treatments, in collaboration with the University of Texas at El Paso and the US Department of Defense, specifically targeting the treatment of Alzheimer's Disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Blood Sepsis and Viremia, and Cancer. Premier Biomedical is based in El Paso, Texas. It also has offices in Pennsylvania. The Company’s shares trade on the OTC Bulletin Board.

In essence, Premier Biomedical is a medical development company specializing in breakthroughs for serious illnesses. The Company has licensed the technology behind numerous provisional patents in the U.S. and a PCT Europe National Patent in the areas of Cancer, Sepsis, and Multiple Sclerosis. The Company has developed an aggressive timetable to further the development of these technologies via laboratory, hospital, as well as clinical trials. It has started the development of potential patient trial application lists.

Premier Biomedical announced this past June that the United States Patent Office approved a patent on its proprietary medication Feldetrex ™. The design of this medication is to relieve the symptoms of neuropathic pain and fibromyalgia. 

Premier Biomedical has been evaluating strategies to take its own Anti-CTLA4 breast cancer treatment through the Food and Drug Administration (FDA) approval process over the past few quarters. Its experimentation on the efficacy of its unique, patent-pending formulation of an anti-CTLA-4 breast cancer drug on mice was presented at the peer-reviewed April 5-9, 2014 American Association for Cancer Research Symposium in San Diego, California.

The Company has several other continuing projects, in addition to its Anti-CTLA-4-based breast cancer drug. In two upcoming clinical trials, its plan is to test its Feldetrex™ pain medication, followed by a separate clinical trial of its core technology designed to remove the pathophysiological basis of the disease.

Earlier this month, Premier Biomedical announced the addition of Dr. Patricio F. Reyes to its Scientific Advisory Board effective immediately. Dr. Reyes will report to the Chairman of the Scientific Advisory Board and co-founder of the Corporation, Dr. Mitchell S. Felder, MD, and to the President and Chief Executive Officer, Mr. William A. Hartman. Dr. Reyes, MD, FAAN, board certified and neuropathologist, is Chief Medical Officer and Board Member of the Retired National Football League Players Association.

Premier Biomedical, Inc. (BIEI), closed Friday's trading session at $0.10, up 81.49%, on 90,378 volume with 17 trades. The average volume for the last 60 days is 41,517 and the stock's 52-week low/high is $0.0551/$2.60.

Milestone Scientific, Inc. (MLSS)

SmallCapVoice reported previously on Milestone Scientific, Inc. (MLSS), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Milestone Scientific, Inc. is a foremost medical research and development company whose shares trade on the OTC Markets’ OTCQB. It designs and patents innovative injection technology and its computer-controlled systems make injections precise, efficient, and virtually painless. Its Milestone Medical, Inc. established in 2011 through a joint venture (JV) between Milestone Scientific and Beijing 3H (Heart-Help-Health) Scientific Technology Co., Ltd. for the development, commercialization, manufacturing and marketing of epidural and intra-articular injection instruments. Milestone Scientific has its corporate headquarters in Livingston, New Jersey.

Milestone Medical has developed epidural and intra-articular drug delivery systems based on a patented, painless, computer-controlled injection and drug delivery technology originally developed by Milestone Scientific. Development of the epidural and intra-articular injection systems is now complete. At present, Milestone Medical is pursuing regulatory approval for both injection systems in the United States and the European Union (EU).

Its patented CompuFlo® system and DPS Dynamic Pressure Sensing® technology are inventive technologies. They are relevant for the entire category of subcutaneous drug delivery injections and fluid aspiration. These enable healthcare practitioners to achieve multiple unique benefits that cannot currently be accomplished with the manual syringe. The technical advantages of the CompuFlo system with DPS Dynamic Pressure Sensing technology include precise controlling and monitoring of all critical variables during drug delivery.

The Dynamic Pressure Sensing® (DPS) capability provides visual and audible in-tissue pressure feedback. DPS provides medical practitioners the ability to identify tissue types and inject drugs at precisely the right location, doing away with guesswork. In addition, the disposable injection hand piece allows for precise tactile control during an injection. Milestone Scientific currently sells its award-winning products by way of an international distribution network serving North America, Asia, Africa and Europe.

Recently, Milestone Scientific announced that its recently formed Joint Venture, Milestone Ophthalmic Sp. z o.o., plans to merge with Emmerson Wierzytelnosci Hipoteczne S.A. (EWH). This is to effect a listing of its common stock on the New Connect market of the Warsaw Stock Exchange, subject to certain final terms and conditions of the merger agreement.

Milestone Ophthalmic's planned merger with EWH follows a recent agreement between Astoria Capital S.A. and Milestone Scientific where the two companies formed Milestone Ophthalmic Sp. z o.o. With this agreement, Milestone Scientific will grant Milestone Ophthalmic the worldwide exclusive rights to its technology for use in intravitreal injections (Ophthalmic Instrument). Intravitreal injection is the placement or delivery of medications or other substances into the eye.

Milestone Scientific, Inc. (MLSS), closed Friday's trading session at $1.86, down 0.63%, on 4,037 volume with 15 trades. The average volume for the last 60 days is 10,775 and the stock's 52-week low/high is $1.17/$2.25.

Solar Power, Inc. (SOPW)

SmallCapVoice and TopPennyStockMovers reported on Solar Power, Inc. (SOPW), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

Solar Power, Inc. {SPI Solar (SPI)} is a vertically-integrated photovoltaic solar developer headquartered in San Francisco, California. It offers its own brand of high-quality, low-cost distributed generation and utility-scale solar energy facility development services. SPI Solar has evolved from a photovoltaic (PV) solar manufacturer and developer, into a top turnkey solar energy facility (SEF) developer. SPI Solar lists on the OTC Markets’ OTCQB.

The Company delivers turnkey world-class photovoltaic solar energy facilities and turnkey residential solar solutions to its business, government and utility customers. This runs the scale from project development, to project financing and to post-construction asset management. SPI Solar develops distributed generation SEFs to provide onsite electricity production for commercial and industrial enterprises.

SPI Solar also develops utility-scale SEFs to provide electricity to power grids serving sizeable areas. The Company’s strategy is to work as a vertically integrated, turnkey solar developer or EPC Contractor to design, engineer and construct high-quality, low-cost photovoltaic SEFs for commercial and industrial enterprises.

The design of its SkyMount® is to provide the most unique features in a commercial rooftop racking system available today. It is engineered with the resilience of aluminum, stainless steel, and Galvalume®.  An optional all aluminum and stainless steel SkyMount is also available.

Today, SPI Solar announced that its wholly-owned subsidiary, Xinyu Xinwei New Energy Co., Ltd., signed engineering, procurement and construction (EPC) agreements for 100 megawatts (MW) of solar PV projects in Julu County, Hebei Province, China. The three separate agreements call for the development of two rooftop sites for ecological agricultural farm rooftop installations, and a distributed grid (DG) project.

SPI Solar will exhibit at the Solar Power International 2014 conference and tradeshow in Las Vegas, Nevada - October 21-23, 2014. The Company will present its offering of Yes!® Solar residential PV systems and turnkey business solution for qualified professional installers. Yes!® Solar provides a complete PV solar business solution by way of a single source for its dealer/installers, including system financing. Yes!® Solar systems allow for quick and simple high-quality installations and it is a turnkey solution. 

Solar Power, Inc. (SOPW), closed Friday's trading session at $2.09, up 11.76%, on 344,920 volume with 258 trades. The average volume for the last 60 days is 498,656 and the stock's 52-week low/high is $0.15/$1.87.

Mojo Organics, Inc. (MOJO)

SmallCap Network reported previously on Mojo Organics, Inc. (MOJO), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Mojo Organics, Inc. engages in product development, production, marketing and distribution, of Chiquita Tropicals™.  A 100 percent fruit juice, Chiquita Tropicals™ are produced under license agreement from Chiquita Brands LLC. The fruit juices first became commercially available in the New York tri-state area in late July of 2013.  Mojo Organics is based in Jersey City, New Jersey.

The Company’s mission is to promote a better-for-you lifestyle for everyone, with affordable natural ingredient beverages and organic ingredient beverages. Chiquita Tropicals™ have zero added sugar, no preservatives, are naturally low sodium, and are vegan, naturally gluten free, non-genetically modified, as well as kosher. 

The line has launched its first four 100 percent fruit juice products made from tropical fruits: Banana Strawberry, Mango, Pineapple, and Passion Fruit. Due to the Company’s cold fill bottling process first developed in Europe Chiquita Tropicals™ do not require refrigeration before opening.

The packaging for this product line is ergonomically designed and easy to hold. Mojo Organics uses Rainforest Alliance Certified fruits. This helps farmers and their families, while being environmentally, socially, and economically sustainable.

Mojo Organics began selling its products on Amazon.com in August of 2013. In January of this year, Mojo Organics announced that it received its first order from Wal-Mart for the Company’s line of 12 oz. Chiquita Tropicals™ exotic juice. The Company said that this is the first order for a multi-country sales program with Wal-Mart that Mojo Organics has been working on since earlier in 2013.

In February 2014, Mojo Organics announced that it received its first orders from Performance Food Group and Albertsons for its line of Chiquita Tropicals™. Performance Food Group delivers over 140,000 national and proprietary-branded food and food-related products to more than 163,000 independent and national chain restaurants, quick-service eateries, pizzerias, schools, hotels, health care facilities, and other institutions. Albertsons, based in Boise, Idaho, has 1,119 supermarkets located in 29 U.S. states operating under 12 different banners.

Mojo Organics, Inc. (MOJO), closed Friday's trading session at $0.25, even for the day. The average volume for the last 60 days is 19,297 and the stock's 52-week low/high is $0.121/$3.15.

Detwiler Fenton Group, Inc. (DMCD)

The Stock Psycho and Darth Trader reported earlier on Detwiler Fenton Group, Inc. (DMCD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Detwiler Fenton Group, Inc. by way of its subsidiaries, provides financial services to institutional and individual investors chiefly in the United States. The Company previously went by the name Detwiler, Mitchell & Co. Founded in 1962, the Company has its corporate head office in Boston, Massachusetts. The Company is a premier, full-service, boutique investment firm with a presence in Boston and New York, New York. Detwiler Fenton Group’s shares trade on the OTC Markets’ OTCQB.

The Company offers institutional channel research and wealth management/investment brokerage services to high net worth and other individuals. In addition, Detwiler Fenton markets annuities and life insurance, health insurance, and long term care products, as well as mutual funds.

Pertaining to capital markets, it operates through Detwiler Fenton & Co. This is a full spectrum broker dealer. It provides independent, unbiased equity research and sales and trading services to institutional clients. Detwiler Fenton is a pioneer and leader in the field of Channel Research. The Detwiler Fenton Research Team was put together with a focus on integrating analysts and consultants based on their industry experience as opposed to Wall Street experience.

Concerning wealth management, the Company operates through Detwiler Fenton Wealth Management, Inc. This entity offers active support and portfolio management for a select group of high net worth clients.

Regarding investment management, the Company operates through Detwiler Fenton Investment Management, LLC. This is a Securities and Exchange Commission (SEC) Registered Investment Advisor. Detwiler Fenton Investment Management provides tactical management advisory and portfolio management services for clients, endowments, as well as family offices.

Detwiler Fenton Investment Management’s advisory management practice is a holistic application of its institutional research and knowledge-based investing heritage. Detwiler Fenton Investment Management works to provide optimal risk-adjusted returns to its clients with actively-managed strategies. Its focus (when assessing manager candidates) concentrates on track records, well-defined investment processes, as well as differentiated management styles.

Detwiler Fenton Group, Inc. (DMCD), closed Friday's trading session at $0.27, up 125.00%, on 172,658 volume with 118 trades. The average volume for the last 60 days is 9,035 and the stock's 52-week low/high is $0.067/$0.52.

Aim Exploration, Inc. (AEXE)

Today we are reporting on Aim Exploration, Inc. (AEXE), here at the QualityStocks Daily Newsletter.

Aim Exploration, Inc. is mining corporation that concentrates on producing mines. It operates as a junior mining company focusing on global mining and exploration. At present, Aim Exploration has two existing projects. One is a 40 percent interest in a Feldspar mine located in the Philippines. The other is an Anthracite coal project located in Peru. The Company has its head office in Beverly Hills, California and operational offices in Manila City, Philippines. Aim Exploration’s shares trade on the OTC Markets’ OTCQB.

Currently, the Feldspar mine is producing and it is undergoing upgrades for expanded production. The operation is controlled in a Joint Venture (JV) with Paladino Management & Development Corp. Recently, Aim Exploration completed a successful test-purchase order for 300 MT. It then received a second test-order for 1,000 MT from the same client and is in the process of completing this order. Aim’s intention is to expand the production facility to include equipment capable of refining the feldspar to be used in clear glass manufacturing. 

Aim’s Anthracite Coal project is considered to be a high grade Anthracite Coal mining property in the Alto Chicama basin, in the province of Otuzco in Peru. Aim SA acquired these rights by purchasing these assets from Percana Mining Corp. (Percana SA), a Peruvian corporation. The Anthracite Coal Project acquisition consists of two mining concession rights consisting of 400 hectares in Lajon Huayobamba Area, in the Huaranchal District of Otuzco Province, Peru.

Furthermore, Aim Exploration has entered into an agreement with Percana to acquire an additional 600 hectares contiguous to the 400 hectare parcel.  Under the agreement, the Company presently has full operational mining and exploration rights on all three properties. The total combined assets encompass 1,000 hectares over an area that is roughly 4,000 meters east west by 3,000 meters north south.

Aim Exploration, Inc. (AEXE), closed Friday's trading session at $0.54, up 5.88%, on 69,419 volume with 67 trades. The average volume for the last 60 days is 44 and the stock's 52-week low/high is $0.20/$1.00.

graphic

The QualityStocks
Company Corner

graphic
graphic

Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.06, even for the day. The stock’s average daily volume over the past 60 days is 89 and its 52-week low/high is $0.06/$1.00.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Western Standard Energy Corp. (WSEG) Changes Corporate Name To Dominovas Energy Corporation (DNRG)

Western Standard Energy Corp. Acquires 100% of Dominovas Energy and Will Change Name to Dominovas Energy Corp.

Western Standard Energy Corp. announces Darren Jacklin as Director

Oriens Travel and Hotel Management Corp. (OTHM)

The QualityStocks Daily Newsletter would like to spotlight Oriens Travel and Hotel Management Corp. (OTHM). Today, Oriens Travel and Hotel Management Corp. closed trading at $0.0003, even for the day, on 18,058,334 volume with 50 trades. The stock’s average daily volume over the past 60 days is 25,719,031, and its 52-week low/high is $0.0001/$0.002.

Oriens Travel and Hotel Management Corp. recently merged with E-Network de Costa Rica SA ("E-Net") -- soon to be known as Pure Hospitality Solutions, Inc. [pending FINRA approval] -- announced today that the Company has completed the submission process for FINRA to enact the merger's resolve; recapitalized Company, new ticker, new name. Oriens is now in the comment period of FINRA's review.

Oriens Travel and Hotel Management Corp. (OTHM) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.

The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Oriens continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.

Operating a successful bi-lateral business model, Oriens has four objectives:

1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;

2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;

3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,

4. Expand the portfolio of Oriens-owned boutique hotels operating under the Hotel PURE brand.

The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.

Ultimately, Oriens intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer

Oriens Travel and Hotel Management Corp. Company Blog

Oriens Travel and Hotel Management Corp. News:

Oriens & E-Net; the Next Steps

Oriens and E-Net Initiate Revenue Plan

Oriens Discusses Recapitalization and Merger

One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.011, up 144.44%, on 469,567 volume with 12 trades. The stock’s average daily volume over the past 60 days is 397,821, and its 52-week low/high is $0.0033/$3.1538.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

The One World Doll Project Announces Financing Relationship With New York Hedge Fund, Blackbridge Capital

One World Holdings, Inc. Announces Engagement of QualityStocks Investor Relations Services

The One World Doll Project Announces New Online Distribution With Toys"R"UsŪ

Mobile Lads Corp. (MOBO)

The QualityStocks Daily Newsletter would like to spotlight Mobile Lads Corp. (MOBO). Today, Mobile Lads Corp. closed trading at $0.374, up 9.97%, on 139,621 volume with 19 trades. The stock’s average daily volume over the past 60 days is 38,396, and its 52-week low/high is $0.1201/$0.40.

Mobile Lads Corp. (MOBO) designs and delivers secure, wide-area wireless transaction software solutions for the consumer finance, web and health payment processing sectors. The company’s solutions provide streamlined, continuous access to time-sensitive information and data on multiple network standards. Mobile Lads’ products and services, offered through its Xtreme Mobility division, centers on three core technologies that simplify and secure wireless communications: xmVerify, xmBilling, and xmOne.

xmVerify is a real-time mobile transaction security service that prevents credit card fraud by giving users control over the authorization process when making purchases. Using one of the best cryptographic services, and in compliance with most all available platforms, xmVerify sends a transaction authorization request directly to the user’s mobile phone to ensure authenticity.

xmBilling is a mobile platform that provides customers with a convenient and secure way to review and authorize automatic billing transactions, easing the challenges of automated and volume-based billing. The system sends the user a text message with a URL leading to an online e-bill where they can review details of the bill and authorize the payment via credit card with the use of their PIN number.

The xmOne mobile platform provides an array of encrypted mobile services, including top-up, payment processing, emergency notification and marketing, ideal for students and higher education facilities. xmOne interfaces with a school’s existing campus card account system to enable students to perform a variety of banking transactions from their cell phones. The university or college benefits from increased usage of the flex-dollar ecosystem, reduces overhead from ADMs, and can be customized to each school’s individual brand.

Mobile Lads is guided by a management team with a unique blend of in-depth technical expertise in wireless channel communications and a solid background in business strategy and consumer analysis. The company’s vision is to grow as a leading-edge wireless solution provider by enabling innovative, wide-area communication solutions on a global scale. Disclaimer

Mobile Lads Corp. Company Blog

Mobile Lads Corp. News:

Mobile Lads Acquires Innovative Online Coupon Platform, CouBox

Mobile Lads Signs Reseller Agreement With Smart Mobile Rewards

Mobile Lads Signs Letter of Intent for Xtreme Mobility Software Acquisition

Sibling Group Holdings, Inc. (SIBE)

The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.1248, up 8.52%, on 57,701 volume with 12 trades. The stock’s average daily volume over the past 60 days is 42,035, and its 52-week low/high is $0.031/$0.24.

Sibling Group Holdings, Inc. (SIBE) is enhancing and delivering 21st century learning with advanced technology and education management operations. Accessing funds from the public capital markets is part of the company’s unified strategy to accelerate the improvement of Pre-K, K-12 and post-secondary education around the world. Better educated children and adults, sustainable and cost effective instructional models, and reduced dependence on governmental funding are the end results.

Existing offerings include professional development for the teaching profession; educational technology, including classroom management tools; a comprehensive and flexible online curriculum; an aggregation platform for massive open online courses, and academic and skills credentialing. Investments are being made in specialized curriculum such as STEM (science, technology, engineering and math), ESL (english as a second language), SEL (social and emotional learning), and Special Ed aimed at supporting students with special needs and their teachers.

Sibling Group is acquiring various Ed-tech businesses and components with the goal of building the first complete solution for the delivery and management of educational content, and tracking educational results, in the digital media – from curriculum to course certification. The recent acquisition of Blended Schools Network (BSN), which serves over 160 school districts with 300,000 course enrollments and currently offers 212 different online courses, is a great example and has provided Sibling Group with extensive infrastructure and solid groundwork for growth in a rapidly growing industry.

IBIS Capital is forecasting fifteen-fold growth in the e-learning market over the next 10 years and has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever observed in the media industry. With a strong, highly experienced management team, Sibling Group is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer

Sibling Group Holdings, Inc. Company Blog

Sibling Group Holdings, Inc. News:

Sibling's Blended Schools Network and LoudCloud Team Up to Accelerate Online Learning

Sibling Group Holdings, Inc. President David Saba, to Be Interviewed LIVE on Clear Channel Business Talk Radio -- (September 30, 2014)

Sibling's Blended Schools Network Division Offers Special Education Professional Development for All Educators

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.40, up 0.25%, on 163,366 volume with 46 trades. The stock’s average daily volume over the past 60 days is 80,784, and its 52-week low/high is $0.15/$1.00.

Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.

Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.

The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.

Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.

Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer

Zenosense, Inc. Company Blog

Zenosense, Inc. News:

Zenosense, Inc. Update -- MRSA and Lung Cancer Device Development

Zenosense, Inc. Begins Development of Lung Cancer Detection Device

Zenosense, Inc. Highlights Recent Media Coverage of MRSA

Boreal Water Collection, Inc. (BRWC)

The QualityStocks Daily Newsletter would like to spotlight Boreal Water Collection, Inc. (BRWC). Today, Boreal Water Collection, Inc. closed trading at $0.013, up 8.33%, on 205,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 837,794, and its 52-week low/high is $0.0032/$0.03.

Boreal Water Collection, Inc. (BRWC) is an established water bottler of premium private-labeled bottled water products tailored for each client’s particular need, be it publicity, promotion, marketing, internal use or a specific event. This emphasis on customization and quality has earned Boreal an impressive reputation, evidenced by its prestigious customer base of high-end beverage brands, retailer channels, high-end hotels and restaurant chains such as H&M, Mercedes, W Hotels, Dean & Deluca, Fred Water, Wat-aah, Saks Fifth Ave, Balance Water, NY Quin Hotel, Bouchon Bakery and Princeton University, just to name a few!

Located 90 miles north New York City, Boreal’s plant is only 17 miles from its well-protected source of natural spring water, a pristine and abundant spring source deep inside the heart of the Catskill Mountains. The spring’s exceptional geological and geographical features have created the perfect environment for Boreal’s low-mineral, sodium-free and well-balanced PH water. With exclusive exploitation rights, Boreal has a confirmed volume in excess of thousands of millions of gallons.

Boreal offers a line of award-winning water products, including functional enhanced water, infused water, carbonated water, vitamins enhanced water, flavored still or sparkling, minerals enhanced water, oxygenated water, electrolyte water, distilled water, alkaline water, caffeinated water and natural spring water.

Accommodating this plentiful water supply and range of product offerings, Boreal has established a 75,000-square foot manufacturing facility. Boreal can process a full range of water and bottle types and has the most creative staff for all private labeling needs. The company offers fully integrated turnkey service, made-to-order labeling along with distinctive water bottles. In short, Boreal is a “Boutique Bottler” and is focusing on becoming the leader of this attractive niche of the growing multi-billion dollar bottled water industry. Disclaimer

Boreal Water Collection, Inc. Company Blog

Boreal Water Collection, Inc. News:

Boreal Water Collection Signs With Plaza del Sol on Fisher Island Miami, Florida

Boreal Water Collection Signs Bottling Agreement with "Water with a Vision," a Water Advertizing Company That Disseminates Mission Statements and QR Code via Personalized Bottled Water

Boreal Water Collection Lands Large Distribution Agreement with COFCO, the Largest Products Supplier and Services in China and Receives the First Order for 10 Containers of Boreal Baby Water

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(OWOO)

2.

Real Pennies
(SPOR)

3.

WealthMakers
(IBIO)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251